Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Inflammatory Bowel Diseases (IBD) Treated Immunomodulators and Biologics

NCT01019837 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

200

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza H1N1

Interventions

BIOLOGICAL: Focetria (Monovalent MF59-Adjuvanted vaccine)

Sponsor

Tel-Aviv Sourasky Medical Center